# FLUTICASONE PROPIONATE
> **ANDA219232** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2026-08-18
## Drug
- **FDA Application Number:** ANDA219232
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUTICASONE PROPIONATE
- **Generic name:** FLUTICASONE PROPIONATE
- **Active ingredients:** FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK SPECLT
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2026-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219232)
---
*MORVS · CC0 1.0*